Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%
- Check18 days agoChange DetectedUpdate to revision v3.1.0 and new contact numbers added; removal of a Genetic and Rare Diseases Information Center resource on ovarian cancer (v3.0.2).SummaryDifference0.5%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedPage revised to v3.0.2; 'Back to Top' link removed. No substantive content changes detected.SummaryDifference0.2%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check47 days agoChange DetectedThe web page has updated its core content by adding specific resources related to ovarian cancer and the facility name and location, while removing several related topics and terms. Notably, the revision version has changed from v2.16.12 to v3.0.0.SummaryDifference5%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.